Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cancer Science|April 17, 2018
Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 womenSatomi Aoyama-Kikawa, Hiromasa Fujita, Sharon J B Hanley, et al.
Journal of Gynecologic Oncology|January 20, 2021
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancerKazuhiro Takehara, Takashi Matsumoto, Junzo Hamanishi, et al.
Journal of Gynecologic Oncology|July 26, 2024
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 studyHiroaki Itamochi, Nobuhiro Takeshima, Junzo Hamanishi, et al.
Annals of Surgical Oncology|June 24, 2023
EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After SurgeryToshiya Fujiwara, Kazuhiko Shien, Motoki Matsuura, et al.
The Annals of Thoracic Surgery|May 20, 2022
Clinical Features of Patients With Second Primary Lung Cancer After Head and Neck CancerFumiaki Takatsu, Ken Suzawa, Mikio Okazaki, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 8, 2023
Surgical outcome of ipsilateral anatomical resection for lung cancer after pulmonary lobectomyMikio Okazaki, Ken Suzawa, Kazuhiko Shien, et al.
Journal of Gynecologic Oncology|December 16, 2020
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancerAikou Okamoto, Eiji Kondo, Toshiaki Nakamura, et al.
Journal of Gynecologic Oncology|September 9, 2024
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 studyDaisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, et al.
Respiratory Research|July 25, 2016
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)Takekazu Iwata, Ichiro Yoshino, Shigetoshi Yoshida, et al.
Melanoma Research|April 4, 2022
Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s)Mitsutake Yano, Kaei Nasu, Masanori Yasuda, et al.
Pageof 8